Navigating Contradictions: Insights from the Latest Behavioral Health Earnings Call
Tuesday, May 20, 2025 3:36 pm ET
None
Financial Performance and Guidance:
- Acadia reported revenue of $770.5 million for Q1 2025, slightly above the midpoint of its outlook range of $765 million to $775 million.
- Adjusted EBITDA for the quarter was $134.2 million, near the high end of the outlook range of $130 million to $235 million.
- The company reaffirmed its full-year financial guidance ranges for both revenue and adjusted EBITDA.
Patient Volume and Bed Additions:
- Same facility patient days grew 2.2% in Q1 2025, including an unfavorable leap year impact of 110 basis points.
- Acadia added 378 new beds in Q1, including 90 beds to existing facilities and 288 beds from two new facilities.
- The company plans to add between 801,000 total beds for 2025 and expects to add between 608 beds annually over 2026 to 2028.
Operational and Quality Initiatives:
- Acadia emphasized its commitment to quality and safety, with measures like patient monitoring systems and mandatory de-escalation training.
- The company's integrated quality dashboard provides real-time visibility into over 50 key performance indicators, supporting its multilayered patient protection approach.
- These initiatives are part of Acadia's strategy to improve underlying labor trends and reduce premium pay, which declined on both a sequential and year-over-year basis in Q1.
Impact of Policy and Payer Rates:
- The company acknowledged the impact of government policy on its operations and expressed optimism about the continued support for its services.
- Acadia expects Medicaid supplemental payments to be flat to up $15 million for 2025 on a net basis, inclusive of the new Tennessee program.
- Payer rate updates have been cautious, with low single-digit same facility revenue per day growth expected for the full year.

Financial Performance and Guidance:
- Acadia reported revenue of $770.5 million for Q1 2025, slightly above the midpoint of its outlook range of $765 million to $775 million.
- Adjusted EBITDA for the quarter was $134.2 million, near the high end of the outlook range of $130 million to $235 million.
- The company reaffirmed its full-year financial guidance ranges for both revenue and adjusted EBITDA.
Patient Volume and Bed Additions:
- Same facility patient days grew 2.2% in Q1 2025, including an unfavorable leap year impact of 110 basis points.
- Acadia added 378 new beds in Q1, including 90 beds to existing facilities and 288 beds from two new facilities.
- The company plans to add between 801,000 total beds for 2025 and expects to add between 608 beds annually over 2026 to 2028.
Operational and Quality Initiatives:
- Acadia emphasized its commitment to quality and safety, with measures like patient monitoring systems and mandatory de-escalation training.
- The company's integrated quality dashboard provides real-time visibility into over 50 key performance indicators, supporting its multilayered patient protection approach.
- These initiatives are part of Acadia's strategy to improve underlying labor trends and reduce premium pay, which declined on both a sequential and year-over-year basis in Q1.
Impact of Policy and Payer Rates:
- The company acknowledged the impact of government policy on its operations and expressed optimism about the continued support for its services.
- Acadia expects Medicaid supplemental payments to be flat to up $15 million for 2025 on a net basis, inclusive of the new Tennessee program.
- Payer rate updates have been cautious, with low single-digit same facility revenue per day growth expected for the full year.

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.